Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Here, we describe the assembly of recombinantly expressed and/or chemically synthesized protein fragments via this chemoselective bioconjugation reaction
You should not use the information on this website or in the editorials for diagnosing or treating a health concern or disease, or for the replacement of prescription medication or other treatment.
HERTHENA-Lung01, a phase II trial of patritumab deruxtecan (HER3-DXd) in epidermal growth factor receptor-mutated non-small-cell lung cancer after epidermal growth factor receptor tyrosine kinase inhibitor therapy and platinum-based chemotherapy
The NHS notes pain and itching at the injection site as common and self-limiting
US$ 21.34
US$ 26.83
US$ 20.74
